Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Alzheimer”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Large-scale testing (Phase 3)Study completedNCT00478205
What this trial is testing

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 1,467
Large-scale testing (Phase 3)Ended earlyNCT00857649
What this trial is testing

Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 369
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Post-approval studies (Phase 4)Study completedNCT00800709
What this trial is testing

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 26
Not applicableNot Yet RecruitingNCT06978946
What this trial is testing

Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients

Who this might be right for
Alzheimer DiseaseLewy Body Dementia (LBD)Frontotemporal Dementia (FTD)+2 more
RenJi Hospital 85
Testing effectiveness (Phase 2)Study completedNCT01513967
What this trial is testing

SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

Who this might be right for
Healthy VolunteersModerate to Severe Alzheimer Patients
Regenera Pharma Ltd 39
Post-approval studies (Phase 4)Ended earlyNCT00649220
What this trial is testing

Memantine and Antipsychotics Use

Who this might be right for
Alzheimer's Disease
Merz Pharmaceuticals GmbH 19
Large-scale testing (Phase 3)Ended earlyNCT00679627
What this trial is testing

Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Research & Development, LLC 2,051
Large-scale testing (Phase 3)Ended earlyNCT01066546
What this trial is testing

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 5
Testing effectiveness (Phase 2)Study completedNCT02431468
What this trial is testing

A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Neurotrope Bioscience, Inc. 147
Large-scale testing (Phase 3)Ended earlyNCT00857233
What this trial is testing

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 297
Large-scale testing (Phase 3)Ended earlyNCT00954590
What this trial is testing

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Moderate to Severe Alzheimer
Medivation, Inc. 89
Large-scale testing (Phase 3)Study completedNCT00097916
What this trial is testing

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 34
Post-approval studies (Phase 4)UnknownNCT00866060
What this trial is testing

Donepezil and Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Moderate to Severe Alzheimer's Disease
King's College London 800
Early research (Phase 1)Not Yet RecruitingNCT07554872
What this trial is testing

Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Shanghai Mental Health Center 9
Post-approval studies (Phase 4)WithdrawnNCT00375557
What this trial is testing

Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients

Who this might be right for
Alzheimer's DiseaseDementiaBehavioral Symptoms
University of Cincinnati
Large-scale testing (Phase 3)Study completedNCT00322153
What this trial is testing

The Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Dementia of the Alzheimer's Type
Forest Laboratories 677
Large-scale testing (Phase 3)WithdrawnNCT04187547
What this trial is testing

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Who this might be right for
Alzheimer's Disease
Cerecin
Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Not applicableTemporarily pausedNCT03484143
What this trial is testing

Neuro RX Gamma - Pivotal Phase

Who this might be right for
Alzheimer Disease
Vielight Inc. 228
Next Page